MAXIDEX

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Lithuania, Malta, New Zealand, Nigeria, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug MAXIDEX contains one active pharmaceutical ingredient (API):

1	Dexamethasone UNII 7S5I7G3JQL - DEXAMETHASONE
	Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.
	Read more about Dexamethasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MAXIDEX Eye drops, suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BA01	Dexamethasone	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1288T, 5565X
BR	Câmara de Regulação do Mercado de Medicamentos	500902501161319, 500902502176311
CA	Health Products and Food Branch	00042560, 00042579
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.631-04-04
EE	Ravimiamet	1090932, 1124288
ES	Centro de información online de medicamentos de la AEMPS	42666
FR	Base de données publique des médicaments	65238711
GB	Medicines & Healthcare Products Regulatory Agency	144896, 14919
HK	Department of Health Drug Office	16913, 46126
HR	Agencija za lijekove i medicinske proizvode	HR-H-085077338, HR-H-444452701
LT	Valstybinė vaistų kontrolės tarnyba	1001229, 1015648, 1077967, 1078905, 1083467, 1086008, 1086779, 1091414
MT	Medicines Authority	MA1249/01101, PI908/15101A
NG	Registered Drug Product Database	04-1593
Switch country to Nigeria in order to find specific presentations of MAXIDEX
NZ	Medicines and Medical Devices Safety Authority	1064, 1065
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63597001
SG	Health Sciences Authority	04153P, 04840P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504440515, 8699504710144
US	FDA, National Drug Code	0998-0615